#Canada #Toronto #Xtalks #VIPS PRO #CCRM/OmniaBio

Accelerating Cell Line Development: Join Our Upcoming FREE Webinar

The landscape of cell line development is constantly evolving, and on June 2 and June 3, 2026, a notable free webinar will be hosted by Xtalks. In this session, attendees will gain invaluable insights into how early confirmation of clonality can bolster the development of cell lines, minimize rework, and ensure compliance with Good Manufacturing Practice (GMP) workflows.

What to Expect from the Webinar

The webinar titled From hPSCs to Epithelial Cell Lines: Accelerating IND-Enabling Cell Line Development with VIPS PRO aims to help participants understand the critical aspects of generating clonal, edited cell lines. Experts will share effective strategies that can lead to high-quality, audit-ready evidence of clonality without compromising downstream efficiency.

Specifically, attendees will learn about the early, unambiguous proof of clonality from the very first day. With practical insights shared by the esteemed speakers from CCRM/OmniaBio, the session promises to deliver information that is pivotal for enhancing workflows in the field of biomedical research and production.

Key Discussion Points

• - Reducing Manual Handling: Manual interventions are often a bottleneck in workflows. This webinar will explore ways to minimize such manual handling and its associated risks.
• - Optimized Clonality Documentation: Gain an understanding of how CCRM/OmniaBio developed standardized clonality documentation to facilitate smoother, GMP-compliant workflows.
• - Minimizing Workflow Variability: Learn how to enhance workflow consistency and learn about the practical considerations for integrating early clonality confirmation into GMP-minded cell line development (CLD) workflows.

The Importance of Epithelial Cell Lines

Epithelial cell lines provide essential platforms for producing therapeutic proteins in Cell and Gene Therapy (CGT). However, these lines face challenges due to the lack of optimized single-cell seeding workflows. The traditional reliance on manual handling has often led to ambiguous records and repeated subcloning, ultimately causing delays in downstream characterization and technology transfer.

According to the speakers, generating clonal, robust epithelial cell lines with clear evidence of clonality is critical in overcoming these challenges. This tie-in underscores the importance of automating workflows and implementing high-throughput assays for better efficiency and reliability.

Real-World Applications Shared

Attendees will not only learn theoretical knowledge but also hear about real-world implementations from a Contract Development and Manufacturing Organization (CDMO) setting. The speakers will provide detailed case studies demonstrating how early confidence in clonal lines can mitigate risks associated with downstream development and enable scalable workflows that adhere to GMP standards.

Adam Causer, Global Product Manager for the Solentim Portfolio at Nova Biomedical, and Sakthi Moorthy, Lead Scientist III at the Centre for Commercialization of Regenerative Medicine, will provide their unique perspectives during the event. The webinar will occur as follows:

• - June 2, 2026, at 10 AM EDT (4 PM CEST/EU-Central)
• - June 3, 2026, at 3 PM CST/China (5 PM AEST/AU-Eastern)

Why You Should Attend

Joining this webinar is an opportunity for professionals in the fields of pharma, biotech, healthcare, and research to enhance their understanding of effective cell line development strategies. Whether you’re a scientist, researcher, or involved in regulatory compliance, the insights shared here will aid in streamlined processes and improved outcomes.

To register for this enlightening session, visit Xtalks. Don't miss out on this opportunity to advance your knowledge and possibly transform your workflows using cutting-edge techniques in cell line development!